Trend of HIV Transmitted Drug Resistance After the Introduction of Single-Tablet Regimens in Southern Taiwan

References

• Palella FJ, Armon C, Buchacz K, et al. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med. 2009;151:73–84. doi:10.7326/0003-4819-151-2-200907210-00003
   PubMed Web of Science ®Google Scholar
• Kuritzkes DR, Lalama CM, Ribaudo HJ, et al. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. J Infect Dis. 2008;197:867–870. doi:10.1086/528802
   PubMed Web of Science ®Google Scholar
• Wittkop L, Günthard HF, de Wolf F, et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 2011;11:363–371. doi:10.1016/S1473-3099(11)70032-9
   PubMed Web of Science ®Google Scholar
• Wu SB, Huang YC, Huang YF, Huang JC. Estimating HIV incidence, prevalence, and percent of undiagnosed infections in Taiwan using CD4 data. J Formos Med Assoc. 2022;121:482–489. doi:10.1016/j.jfma.2021.05.030
   Web of Science ®Google Scholar
• Taiwan center for diseases control HIV monthly report. Available from: https://www.cdc.gov.tw/File/Get/9dT-gsPC46au0kRYIw9Drw. Accessed April 1, 2022.
   Google Scholar
• Huang YC, Sun HY, Chuang YC, et al. Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: real-world experience from a single-centre retrospective cohort in Taiwan. BMJ Open. 2019;9:e033246. doi:10.1136/bmjopen-2019-033246
   PubMed Web of Science ®Google Scholar
• Weng YW, Tsai HC, Lee SS, et al. Prevalence and associated factors for HIV-1 transmitted drug resistance in voluntary clients for counseling and testing in Southern Taiwan. J Microbiol Immunol Infect. 2016;49:487–493. doi:10.1016/j.jmii.2014.08.002
   PubMedGoogle Scholar
• Lai CC, Liu WC, Fang CT, et al. Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan. J Antimicrob Chemother. 2016;71:226–234. doi:10.1093/jac/dkv284
   PubMed Web of Science ®Google Scholar
• Chang SY, Lin PH, Cheng CL, et al. Prevalence of Integrase Strand Transfer Inhibitors (INSTI) resistance mutations in Taiwan. Sci Rep. 2016;6:35779. doi:10.1038/srep35779
   PubMed Web of Science ®Google Scholar
• Tsai HC, Chen IT, Tsai KW, Lee SS, Chen YS. Prevalence of HIV-1 Integrase strand transfer inhibitor resistance in treatment-naïve voluntary counselling and testing clients by population sequencing and illumina next-generation sequencing in Taiwan. Infect Drug Resist. 2020;13:4519–4529. doi:10.2147/IDR.S273704
   Web of Science ®Google Scholar
• Bangsberg DR, Ragland K, Monk A, Deeks SG. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS. 2010;24:2835–2840. doi:10.1097/QAD.0b013e328340a209
   PubMed Web of Science ®Google Scholar
• Cotte L, Ferry T, Pugliese P, et al. Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large French multicenter cohort study. PLoS One. 2017;12:e0170661. doi:10.1371/journal.pone.0170661
   PubMed Web of Science ®Google Scholar
• Airoldi M, Zaccarelli M, Bisi L, et al. One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Prefer Adherence. 2010;4:115–125. doi:10.2147/ppa.s10330
   PubMed Web of Science ®Google Scholar
• Tsai HC, Chou PY, Wann SR, Lee SS, Chen YS. Chemokine co-receptor usage in HIV-1-infected treatment-naïve voluntary counselling and testing clients in Southern Taiwan. BMJ Open. 2015;5:e007334. doi:10.1136/bmjopen-2014-007334
   Web of Science ®Google Scholar
• Huang SW, Shen MC, Wang WH, et al. High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan. J Antimicrob Chemother. 2021;77:185–195. doi:10.1093/jac/dkab361
   Web of Science ®Google Scholar
• Canducci F, Barda B, Ceresola E, et al. Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption. Clin Microbiol Infect. 2011;17:928–934. doi:10.1111/j.1469-0691.2010.03375.x
   PubMed Web of Science ®Google Scholar
• Canducci F, Ceresola ER, Boeri E, et al. Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir. J Infect Dis. 2011;204:1811–1815. doi:10.1093/infdis/jir636
   PubMed Web of Science ®Google Scholar
• Wensing AM, Calvez V, Ceccherini-Silberstein F, et al. update of the drug resistance mutations in HIV-1. Top Antivir Med. 2019;2019(27):111–121.
   Google Scholar
• Stanford University HIV drug resistance database. Available from: https://hivdb.stanford.edu. Accessed June 2, 2021.
   Google Scholar
• Chan DP, Sun HY, Wong HT, Lee SS, Hung CC. Sexually acquired hepatitis C virus infection: a review. Int J Infect Dis. 2016;49:47–58. doi:10.1016/j.ijid.2016.05.030
   PubMed Web of Science ®Google Scholar
• Braitstein P, Justice A, Bangsberg DR, et al. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS. 2006;20:323–331. doi:10.1097/01.aids.0000198091.70325.f4
   PubMed Web of Science ®Google Scholar
• Gonzalez-Serna A, Macias J, Palacios R, et al.; HEPAVIR study group. Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain. HIV Med. 22;2021:379–386. doi:10.1111/hiv.13039
   Web of Science ®Google Scholar
• Chang SY, Chen MY, Lee CN, et al. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J Antimicrob Chemother. 2008;61:689–693. doi:10.1093/jac/dkn002
   Web of Science ®Google Scholar